Implantable electrode for intracranial tumor treatment and electric field treatment device
Through the design of flexible electrodes and biocompatible materials, the fever, adverse reactions and positional instability of intracranial tumor electrode treatment in the prior art are solved, and more efficient and stable electric field treatment is achieved, and patient compliance is improved. and therapeutic effects.
Patent Information
- Application Number
- CN202411292570.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-09-14
AI Technical Summary
The existing intracranial tumor electrode treatments have problems such as fever, adverse reactions, unstable position and poor patient compliance, especially external electrodes cause scalp inflammation and allergies, and implanted electrodes have biocompatibility problems in fixation mode and Risk of intracranial injury.
Flexible electrodes, including flexible basal layer and electrode units, are placed in the tumor cavity after tumor resection, and the extension section is attached to the surface of brain tissue. The material design of the flexible basal layer and conductive layer ensures the stability of the electrode and Biocompatibility and a control module are combined to generate an AC electric field.
More precise targeted tumor therapy is achieved, which reduces adverse reactions, improves the stability of electric field treatment and patient compliance, reduces the impact of impedance of the skull and scalp, extends the treatment time, and enhances the treatment effect.
Smart Images

Figure CN119055949A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical devices, and in particular to an implantable electrode and an electric field treatment device for treating intracranial tumors. Background Art
[0002] Gliomas are the most common malignant tumors in the brain. They are a general term for tumors that originate from glial cells and neuronal cells in the nervous system, accounting for 40% to 50% of the total number of intracranial tumors. The median survival of patients with glioblastoma is between 14.6 months and 17 months. It is a malignant disease that seriously affects human health and quality of life. At present, surgical resection is still the main treatment for gliomas. However, due to the diffuse growth of the tumor, there is no clear boundary between the tumor and normal tissue. In order to protect normal physiological functions, it is difficult to achieve complete resection in practice. Clinically, it has also been found that the tumor has a high probability of recurrence after surgery and a poor prognosis. Most importantly, there is a blood-brain barrier in the skull, and most drugs find it difficult to cross the blood-brain barrier to act on the tumor.
[0003] Tumor electric field therapy is a method of using low-intensity, medium-frequency alternating electric fields to act on the microtubules of proliferating cancer cells, interfering with tumor cell mitosis, thereby inhibiting tumor growth and causing apoptosis of affected cancer cells. Therefore, as a new treatment method, tumor electric field therapy has received widespread attention and recognition from physicians. An international phase III multicenter clinical study on newly diagnosed glioblastoma patients showed that compared with temozolomide (TMZ) chemotherapy alone, the combination of tumor electric field therapy and TMZ significantly improved the patients' progression-free survival (PFS) and overall survival (OS). Studies have confirmed that the five-year overall survival rate (OS) of patients with newly diagnosed glioblastoma treated with tumor electric field therapy combined with temozolomide increased from 5% to 13%, and the median overall survival of patients was extended from 16 months to 20.9 months. The effect of tumor electric field therapy is closely related to compliance, and the median survival of patients with high compliance is significantly prolonged.
[0004] The key core component of the electric field therapy equipment for tumors currently on the market is the electrode, which is an external type. The main structure of the external type is as follows: Figure 1As shown, when there is a tumor 103 in the patient's brain, a commonly used treatment method in the prior art is to attach the attached electrode 101 to the patient's scalp 104. From clinical results, physician and patient surveys and comprehensive analysis, it is known that the external electrode solution has the following shortcomings: First, severe fever will cause adverse phenomena such as inflammation and allergies of the scalp 104; second, the effect is unstable. Since the electrodes need to be frequently replaced and re-attached during the treatment process, the position of each attachment cannot be strictly consistent, which leads to different electric field effects applied to the tumor area; third, patient compliance is poor, because the hair needs to be shaved, and the scalp 104 becomes inflamed and allergic during wearing, and the patient's wearing time of the device will be reduced. Since the treatment effect is directly positively correlated with the wearing time, reducing the wearing time will affect the treatment effect.
[0005] In this regard, the existing technology is committed to studying the implantation of electrodes into the intracranial tumor site to solve the above problems. However, after the existing implantable electrodes are implanted into the tumor resection cavity, they are often led out by wires, and the wires are fixed to the brain tissue or skull outside the tumor cavity by screws, adhesives or sutures. However, this method of lead fixation can easily lead to an unstable position of the electrode in the tumor resection cavity, thereby affecting the effect of electric field therapy. The use of adhesive fixation will have biocompatibility issues and the risk of causing chronic adverse reactions such as inflammation and allergies; in addition, the use of screws, sutures, etc. often leads to further intracranial damage. Summary of the invention
[0006] The present invention is made in view of the defects and shortcomings of the above-mentioned prior art. The purpose of the present invention is to provide an implantable electrode for intracranial tumor treatment, comprising: a flexible electrode, the flexible electrode comprising a flexible substrate and at least one electrode unit arranged on the flexible substrate; at least one end of the flexible substrate is not covered by the electrode unit, and an extension section is formed at the portion of the flexible substrate not covered by the electrode unit.
[0007] In at least one embodiment, the electrode unit of the flexible electrode is used to be placed in a tumor cavity formed after tumor resection, and the extended section of the flexible electrode is used to be attached to the surface of brain tissue outside the tumor cavity.
[0008] In at least one embodiment, in the length direction of the flexible base layer, the flexible electrode includes at least two electrode units spaced apart on the flexible base layer; the two electrode units are located at non-end portions of the flexible base layer.
[0009] In at least one embodiment, the flexible electrode is bent into a "X" shape in the implanted state, wherein at least two of the electrode units are located in the tumor cavity and are arranged opposite to each other, and the two electrode units are configured to generate an alternating electric field; the two ends of the flexible base layer itself are extension segments, and the two extension segments of the flexible base layer are used to extend out of the tumor cavity in opposite directions and adhere to the surface of brain tissue outside the tumor cavity.
[0010] In at least one embodiment, the electrode unit comprises a flexible substrate layer, a conductive layer and a packaging layer covering the flexible substrate layer and the conductive layer, which are sequentially stacked on the flexible substrate layer. The flexible substrate layer and the packaging layer are made of biocompatible materials.
[0011] In at least one embodiment, the material of the flexible base layer includes at least one of polydimethylsiloxane, polyethylene terephthalate, polyimide or polyethylene; the material of the flexible substrate layer includes at least one of thermoplastic polyurethane or medical silicone; the material of the conductive layer includes at least one of carbon nanotubes, graphene, polythiophene, polyaniline, polypyrrole, conductive hydrogel, gold, silver or platinum-iridium alloy; the material of the encapsulation layer includes at least one of polydimethylsiloxane, polyethylene terephthalate, polyimide and a composite high dielectric constant material containing inorganic nanoparticles as fillers. The inorganic nanoparticles can be selected from titanium dioxide, ferroelectric nanoparticles, barium titanate (BaTiO3), etc. When used, the flexible base layer and the flexible substrate layer have good deformation ability, can be bent without breaking, and can adapt to common deformation types such as bending, shaping, uniaxial stretching, biaxial stretching and radial stretching.
[0012] In at least one embodiment, the conductive layer of the flexible electrode is in a rectangular shape, or includes a long strip-shaped trunk and a plurality of spaced-apart branches, and the plurality of spaced-apart branches are integrally connected to one side of the same trunk.
[0013] In at least one embodiment, the extension section of the flexible electrode includes a plurality of through holes penetrating the flexible base layer.
[0014] The electric field treatment device included in the embodiment of the present invention includes: a control module; and the implantable electrode for intracranial tumor treatment as described above, the implantable electrode for intracranial tumor treatment is electrically connected to the control module, and is used to generate an alternating electric field by the implantable electrode; there are at least two implantable electrodes for intracranial tumor treatment, or the implantable electrode for intracranial tumor treatment includes at least two of the electrode units.
[0015] In at least one embodiment, the flexible electrode is a first electrode, the control module is electrically connected to the flexible electrode, the electrode unit of the flexible electrode is used to be placed in the tumor cavity formed after tumor resection, and the extension section of the flexible electrode is used to extend out of the tumor cavity and adhere to the surface of brain tissue outside the tumor cavity; the electric field treatment device also includes at least one second electrode, which is also electrically connected to the control module and is used to be configured outside the tumor cavity, and the control module is configured to generate an alternating electric field between the flexible electrode and at least one second electrode. Preferably, the second electrode is used to be implanted under the skull and above the dura mater.
[0016] In at least one embodiment, the electric field therapy device has two modes: an electric field therapy mode and an impedance measurement mode; preferably, in the electric field therapy mode, the control module transmits alternating current of a certain frequency to the flexible electrode or to the flexible electrode and the second electrode to apply an electric field to tumor cells in the target area; and / or, in the impedance measurement mode, the control module transmits alternating current of a certain frequency range to the flexible electrode or to the flexible electrode and the second electrode to measure the impedance value of the target area.
[0017] Compared with the prior art, the present invention has the following beneficial technical effects:
[0018] (1) Compared with the existing external electrodes, the implantable electrode for intracranial tumor treatment of the present invention can be directly implanted into the tumor cavity after tumor resection, with more precise targeting, and can directly apply the optimal treatment intensity to the nearby tumor residual area; it also has little adverse reaction, no obvious fever, and is not easy to cause scalp inflammation and allergies; it also avoids the obstruction of high-impedance tissues such as the skull and scalp, and can produce a considerable treatment effect based on a relatively low energy input.
[0019] (2) Compared with the existing implantable electrodes, the implantable electrode for intracranial tumor treatment of the present invention can be directly attached to the surface of the tumor cavity by relying on the surface adhesion of the flexible electrode after being implanted into the tumor cavity, and the flexible electrode is further fixed by forming an extension section on the flexible base layer, the extension section extends out of the tumor cavity and is attached to the surface of the brain tissue. The flexible electrode of the present invention is stable in position in the tumor cavity, so that the electric field applied by the flexible electrode to the target area can be stable and will not change significantly. In addition, the implantation method of the flexible electrode is simple and not easy to cause intracranial damage. The flexible electrode can also produce adaptive deformation with the displacement of brain tissue, can work for a long time in the skull, and has higher patient compliance, so the treatment effect is better.
[0020] (3) The electric field treatment device of the present invention includes a first electrode implanted in the tumor cavity and a second electrode implanted outside the tumor cavity, so that the targeting of the tumor electric field treatment is more accurate, and the electric field can cover the residual tumor area to a larger extent, reducing the treatment blind area of the electric field, thereby better preventing tumor recurrence. Moreover, both the first electrode and the second electrode can be well fixed in the body, and there is no need to frequently replace them during the treatment process like external electrodes. The relative position is more stable and the treatment effect is more stable.
[0021] (4) The electric field therapy device of the present invention has a closed-loop control function. The electrodes can not only apply the electric field but also measure the impedance value of the tissue, sense the growth of the tumor in real time, and then adjust the application parameters of the electric field to find the best treatment parameters suitable for each patient and improve the treatment effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0023] Figure 1 This is a schematic diagram of the use status of an implementation method of the prior art;
[0024] Figure 2 is a schematic diagram of a use state of an electric field treatment device according to an embodiment of the present invention;
[0025] Figure 3 is a three-dimensional diagram of a flexible electrode in an embodiment of the present invention in a plane unfolded state;
[0026] Figure 4 is a schematic diagram of a composite structure of an embodiment of an electrode unit of a flexible electrode of the present invention;
[0027] Figure 5 is a shape outline diagram of the conductive layer of the electrode unit of the flexible electrode in the present invention;
[0028] Figure 5 (a) is a shape outline diagram of a first embodiment of a conductive layer of an electrode unit of a flexible electrode in the present invention;
[0029] Figure 5 (b) is a shape outline diagram of a second embodiment of the conductive layer of the electrode unit of the flexible electrode of the present invention;
[0030] Figure 5 (c) is a shape outline diagram of a third embodiment of a conductive layer of an electrode unit of a flexible electrode in the present invention;
[0031] Figure 5 (d) is a shape outline diagram of a fourth embodiment of a conductive layer of an electrode unit of a flexible electrode in the present invention;
[0032] Figure 5 (e) is a shape outline diagram of a fifth embodiment of a conductive layer of an electrode unit of a flexible electrode in the present invention;
[0033] Figure 5 (f) is a shape outline diagram of a sixth embodiment of the conductive layer of the electrode unit of the flexible electrode of the present invention;
[0034] Figure 6 is a schematic diagram of a use state of an electric field treatment device according to an embodiment of the present invention;
[0035] Figure 7 is a shape outline diagram of the conductive layer of the second electrode in the present invention;
[0036] Figure 7 (a) is a shape outline diagram of a first embodiment of a conductive layer of a second electrode in the present invention;
[0037] Figure 7 (b) is a shape outline diagram of a second embodiment of the conductive layer of the second electrode in the present invention;
[0038] Figure 7 (c) is a shape outline diagram of a third embodiment of the conductive layer of the second electrode in the present invention;
[0039] Figure 7 (d) is a shape outline diagram of a fourth embodiment of the conductive layer of the second electrode in the present invention;
[0040] Figure 7 (e) is a shape outline diagram of the fifth embodiment of the conductive layer of the second electrode in the present invention.
[0041] Description of Reference Numerals
[0042] 101-adhesive electrode; 102-brain tissue; 103-tumor; 104-scalp; 105-skull; 20-flexible electrode; 21-flexible base layer; 211-extension section; 212-through hole; 22-electrode unit; 221-flexible base layer; 222-first conductive layer; 2221-trunk; 2222-branches; 2223-conductive sheet; 223-packaging layer; 23-flexible wire; 30-second electrode; 322-second conductive layer; 3221-fixing hole; 3222-radial strip; 3223-circular strip; 3224-vortex strip; R-tumor cavity. DETAILED DESCRIPTION
[0043] The present invention is further described in detail below in conjunction with specific embodiments:
[0044] Embodiment 1
[0045] See also Figures 2 to 6 The present embodiment provides an electric field treatment device, including a control module (not shown) and an implantable electrode for intracranial tumor treatment, the implantable electrode for intracranial tumor treatment being electrically connected to the control module to generate an alternating electric field. The implantable electrode for intracranial tumor treatment comprises a flexible electrode 20, the flexible electrode 20 comprising a flexible substrate layer 21, at least one electrode unit 22 arranged on the flexible substrate layer, and a flexible wire 23, the electrode unit 22 being used to be placed in a tumor cavity R formed after tumor resection, and the flexible electrode 20 can be directly attached to the surface of the tumor cavity R by surface adhesion after being implanted in the tumor cavity R. At least one end of the flexible substrate layer 21 is not covered by the electrode unit 22, and the part of the flexible substrate layer 21 not covered by the electrode unit 22 forms an extension section 211, the extension section 211 is used to extend out of the tumor cavity R and attach to the surface of the brain tissue 102, and the flexible electrode 20 can be further fixed to make it more stable. In addition, the flexible electrode 20 of the present invention is very soft and can produce adaptive deformation with the displacement of the brain tissue 102, thereby reducing the discomfort of the patient and not easily causing damage to the intracranial tissue. The flexible wire 23 is partially embedded in the flexible substrate layer 21 , and one end of the flexible wire 23 is electrically connected to the electrode unit 22 , and the other end of the flexible wire 23 extends out of the flexible substrate layer 21 to be electrically connected to an external control module.
[0046] Among them, the flexible electrode 20 is an extremely thin sheet structure, which can be a square, rectangle, strip or other irregular shapes. The strip here may also include a partial rectangle. The strip mainly refers to a shape with a relatively large length and width and parallel edges on both sides. The flexible electrode 20 is preferably a strip, so that the flexible electrode 20 can be better bent and extended into the tumor cavity R, and can better fit the wall of the tumor cavity R. The thickness of the flexible electrode 20 of the present invention can be 50μm to 1mm, the length can be 8 to 25mm, and the length of the extension section 211 extending out of the tumor cavity R can be 2 to 5mm to increase the reliability of fixation. In practical applications, it can also be set according to the size and shape of the tumor cavity R after the tumor is removed.
[0047] In this embodiment, the flexible electrode 20 can improve the targeting of the electric field therapy by implanting the flexible electrode 20 into the tumor cavity R instead of attaching it to the scalp 104, and can directly apply the best treatment intensity to the tumor residual area near the tumor cavity R, with little adverse reaction, no obvious fever, and not easy to cause inflammation and allergy of the scalp 104. In addition, it avoids the obstruction of high-impedance tissues such as the skull 105 and the scalp 104, and can produce a considerable treatment effect based on a relatively low energy input. Since the flexible electrode 20 is very thin and has good self-adhesion, it can be directly attached to the surface of the tumor cavity R by relying on surface adhesion, and an extension section 211 is formed on the flexible base layer 21 for attaching to the brain tissue 102 at the outer edge of the tumor cavity R, so that the relative position of the flexible electrode 20 is fixed, so that the electric field received by the target area is stable and will not change greatly, and the treatment effect is better; moreover, the flexible electrode 20 can produce adaptive deformation with the displacement of the brain tissue 102, reduce the patient's discomfort, can work for a long time in the skull, and the patient's compliance is higher, so the treatment effect is better.
[0048] In one embodiment, two or more flexible electrodes 20 may be arranged in the tumor cavity R at the same time, and each flexible electrode 20 is bent roughly into an L shape in the tumor cavity R, wherein part of the electrode unit 22 is located in the tumor cavity R, and the extension section 211 is located outside the tumor cavity R and adheres to the surface of the brain tissue 102. The multiple flexible electrodes 20 may be arranged adjacently or oppositely, so that an alternating electric field surrounding the side wall of the tumor cavity R may be generated between the multiple electrode units 22, and the surrounding tissue of the tumor cavity R may be more efficiently and comprehensively acted on, thereby better inhibiting the recurrence of the tumor 103. In another embodiment, each flexible electrode 20 may also be arranged with two or more electrode units 22 side by side in the width direction, so that an alternating electric field surrounding the side wall of the tumor cavity R may be generated between every two electrode units 22.
[0049] See also Figure 3 The extension section 211 of the flexible electrode 20 may also include a plurality of through holes 212 penetrating the flexible substrate layer 21, and the plurality of through holes 212 may be arranged arbitrarily. Preferably, the through holes 212 are arranged at a certain distribution density. By providing the through holes 212 in the extension section 211, the fit between the extension section 211 and the brain tissue 102 may be improved. Moreover, after the flexible electrode 20 is implanted in the tumor cavity R, the brain tissue 102 may migrate and grow on the surface of the extension section 211 and then pass through the through holes 212 during the treatment process, which is more conducive to the fixation of the flexible electrode 20 during the treatment process, thereby improving the stability of the electric field treatment.
[0050] See also Figure 4The electrode unit 22 includes a flexible substrate layer 221, a first conductive layer 222 and an encapsulation layer 223 which are sequentially stacked on the surface of the flexible substrate layer 21. The material of the flexible substrate layer 21 may be polydimethylsiloxane (PDMS), polyethylene terephthalate (PET), polyimide (PI) or polyethylene (PE), etc. The flexible substrate layer 221 has good deformation ability during application, does not break when bent, and is conducive to the deposition of the electrode layer. The material of the flexible substrate layer 221 may be thermoplastic polyurethane (TPU), medical silicone, etc.; the conductive layer 222 must have good electrical conductivity, and its material may be emerging materials such as carbon nanotubes and graphene, conductive polymer materials and hydrogel materials such as polythiophene (PTi), polyaniline (PANI), polypyrrole (PPy), and metal materials such as gold, silver, and platinum-iridium alloy. The material of the encapsulation layer 223 may be PDMS, PI, PET, etc., or may be a composite high dielectric constant material containing inorganic nanoparticles as fillers, such as titanium dioxide, ferroelectric nanoparticles, barium titanate (BaTiO 3 ), etc.
[0051] In this embodiment, the shape of the first conductive layer 222 in the flexible electrode 20 can be selected as follows: Figure 5 As shown, Figure 5 As shown in (a), the shape of the first conductive layer 222 in the flexible electrode 20 can be the most basic rectangle. In addition, the shape outline of the first conductive layer 222 can also be composed of a long strip-shaped trunk 2221 and a plurality of long strip-shaped branches 2222, and a plurality of spaced branches 2222 are integrally connected to one side of the same trunk 2221; a plurality of conductive sheets 2223 larger than the width of the long strip branches 2222 are also spaced apart on the branches 2222, and the shape outline of the conductive sheets 2223 themselves can be a circle, rectangle, diamond, hexagon or other shapes or a combination of two or more shapes. Figure 5 As shown in (b), the trunk 2221 and the branches 2222 of the first conductive layer 222 are each in the shape of a rectangular strip. Figure 5 As shown in (c), the conductive sheet 2223 of the first conductive layer 222 has a circular outline. Figure 5 As shown in (d), the conductive sheets 2223 of the first conductive layer 222 have rectangular outlines. Figure 5 As shown in (e), the conductive sheets 2223 of the first conductive layer 222 have diamond-shaped contours. Figure 5 As shown in (f), the conductive sheet 2223 of the first conductive layer 222 has a hexagonal outline. By providing the trunk 2221, the branch 2222 and the conductive sheet 2223 in the first conductive layer 222, the electrode unit 22 can increase the flexibility and conformability of the flexible electrode 20 while being able to generate an electric field of the required strength and direction, thereby making the electrode 20 more firmly attached to the surface of the tumor cavity R.
[0052] Embodiment 2
[0053] This embodiment provides an electric field treatment device, the structure of which is substantially the same as that of the first embodiment, except that:
[0054] See also Figure 3 and 6 Along the length direction of the flexible base layer 21, the flexible electrode 20 includes at least two electrode units 22 spaced apart from each other on the flexible base layer 21. The electrode units 22 are both located at the non-end portions of the flexible base layer 21. An extension section 211 is formed at opposite ends of the flexible base layer 21.
[0055] After being implanted in the tumor cavity R, the flexible electrode 20 can be roughly bent into a "J" shape, and the two electrode units 22 are spaced and arranged opposite to each other to generate an AC electric field between the two electrode units 22. The two extension sections 211 extend out of the tumor cavity R in opposite directions and are attached to the surface of the brain tissue 102. The two extension sections 211 and the "J"-shaped structure can make the flexible electrode 20 more firmly attached to the surface of the tumor cavity R, and the position can be kept more stable during the subsequent treatment process, thereby improving the electric field treatment effect.
[0056] Embodiment 3
[0057] See also Figure 6 This embodiment provides an electric field treatment device, which includes a control module (not shown) and one or more flexible electrodes 20, wherein the structure of the flexible electrode 20 is substantially the same as that of the first or second embodiment, except that:
[0058] The flexible electrode 20 is defined as a first electrode. The electric field therapy device also includes at least one second electrode 30. The second electrode 30 is arranged outside the tumor cavity R and is electrically connected to the control module. The control module can be configured to generate an alternating electric field between the flexible electrode 20 and the second electrode 30, thereby expanding the direction range of the electric field and improving the electric field therapy effect.
[0059] Specifically, the second electrode 30 can be implanted under the skull 105 and above the dura mater. The overall structure and material composition of the second electrode 30 are substantially the same as those of the flexible electrode 20, and the control module is configured to generate an alternating electric field between the flexible electrode 20 and at least one electrode unit (not shown) of the second electrode 30.
[0060] It can be understood that in practical applications, one or more second electrodes 30 can be set in all areas around the tumor cavity R, and the direction of the electric field can be periodically changed between the second electrode 30 and the flexible electrode 20 to optimize the electric field treatment effect.
[0061] In this embodiment, the electrode unit of the second electrode 30 has a second conductive layer 322 (not shown), the material of which can be selected to be similar to that of the first conductive layer 222, and the shape can be selected as follows: Figure 7 As shown. Figure 7 (a) to Figure 7 As shown in (e), the conductive layer 322 in the second electrode 30 includes more than two fixing holes 3221, so that the second electrode 30 can be fixed to the inner surface of the skull 105 by titanium nails. The shape of the second conductive layer 322 can be rectangular, circular or annular, or as shown in FIG. Figure 7 As shown in (d), the shape of the plurality of concentric ring strips 3223 is formed, wherein the ring strips 3223 are integrally connected to the radial strips 3222, or as shown in Figure 7 (e) shows the shape of the vortex bar 3224, and the fixing holes 3221 are arranged at intervals along the vortex track of the vortex bar 3224. Various shapes of the second conductive layer 201 of the second electrode 30 can be easily installed and fixed in practical applications to generate an electric field of a desired direction and strength as required.
[0062] Embodiment 4
[0063] This embodiment provides an electric field treatment device, which has a substantially similar structure to that of the third embodiment, except that:
[0064] The electric field treatment device has two modes: electric field treatment mode and impedance measurement mode. In the electric field treatment mode, the control module transmits alternating current of a certain frequency to the flexible electrode 20 or to the flexible electrode 20 and the second electrode 30 to apply an electric field to the tumor cells in the target area; in the impedance measurement mode, the control module transmits alternating current of a certain frequency range to the flexible electrode 20 or to the flexible electrode 20 and the second electrode 30 to measure the impedance value of the target area. The target area may include the inner cavity and side walls of the entire tumor cavity R.
[0065] Because tumor tissue usually has a lower impedance value than normal tissue, the growth of the tumor can be detected in real time by measuring the impedance value. In this embodiment, the electric field therapy device has two modes: electric field therapy mode and impedance measurement mode. The conversion between the two modes can be completed by controlling the two modes to work in different time periods. In actual use, for example, the impedance measurement works for 10 minutes every 48 hours, and the remaining time periods are in the electric field therapy mode. In the electric field therapy mode, the voltage is the set voltage, and the frequency is fixed at 200Khz. In the impedance measurement mode, the voltage is fixed to 100Vpp, and then the change measurement is performed within the frequency range of 1-150Khz. Each frequency corresponds to an impedance value, thereby obtaining an impedance measurement curve, and the growth status of the tumor area can be obtained by comparing it with the impedance measurement curve of normal tissue. According to the growth status of the tumor area, the output voltage in the electric field therapy mode can be adjusted accordingly, and the optimal electric field conditions can be applied to the area to achieve closed-loop automatic adjustment, thereby improving the treatment effect as a whole.
[0066] In the electric field therapy mode and the impedance measurement mode, the flexible electrode 20 and the second electrode 30 work together to generate an alternating electric field that can basically cover the entire tumor cavity R and its side walls, thereby improving the electric field therapy effect and accurately measuring the impedance value of the entire tumor cavity R.
[0067] The electric field therapy device has a closed-loop control function. The flexible electrode 20 and the second electrode 30 can not only be used to apply the electric field but also to measure the impedance value of the tumor tissue. The measured impedance value is used as a reference for the growth of the tumor, and then the application parameters of the electric field are adjusted to find the optimal treatment parameters suitable for each patient.
[0068] Embodiment 5
[0069] This embodiment provides an electric field treatment device, which has substantially the same structure as that of the first, second, third or fourth embodiments, except that:
[0070] See also Figure 6 The flexible electrode 20 in the shape of a Chinese character "X" includes an implantation section and an extension section 211, and the implantation section and the extension section 211 form a certain angle, for example, they are perpendicular to each other. This is mainly determined by the shape of the tumor cavity R and the surface curvature of the brain tissue around the tumor cavity R. The implantation section is located in the tumor cavity R, and the two implantation sections are attached to the tumor cavity wall and arranged opposite to each other, and the bottoms of the two implantation sections realize an integrated tangent transition through an arc section, and the tops of the implantation sections realize an integrated tangent transition with the extension section 211 through another arc section. That is, along the length direction of the flexible electrode 20, the flexible base layer 21 is composed of the extension section 211, the arc section, the implantation section, the arc section, the implantation section, the arc section, and the extension section 211 in sequence.
[0071] This embodiment refines the "J"-shaped shape of the flexible electrode 20 , ensuring a smooth transition at the bend of the flexible electrode 20 , thereby avoiding bending loss of the flexible electrode 20 and improving the patient's physiological tolerance to the flexible electrode 20 .
[0072] Embodiment 6
[0073] This embodiment provides an electric field treatment device, which has substantially the same structure as that of the first, second, third, fourth or fifth embodiments, except that:
[0074] See also Figure 3 or Figure 6 The extension direction of the flexible wire 23 does not intersect with the through hole 212 , and the through holes 212 are symmetrically arranged on both sides of the flexible wire 23 according to the total number.
[0075] This embodiment refines the layout position of the through hole 212 . Under the premise of not affecting the fixation of the through hole 212 and the brain tissue 102 , the through hole 212 leaves a connection route for the flexible wire 23 , thereby facilitating the electrical connection between the flexible wire 23 and the electrode unit 22 .
[0076] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with this technology to understand the content of the present invention and implement it. They cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.
Claims
1. An implantable electrode for treating intracranial tumors, characterized in that: include: A flexible electrode (20), the flexible electrode (20) comprising a flexible base layer (21) and at least one electrode unit (22) arranged on the flexible base layer (21); at least one end of the flexible base layer (21) is not covered by the electrode unit (22), and an extension section (211) is formed at a portion of the flexible base layer not covered by the electrode unit (22).
2. The implantable electrode for intracranial tumor treatment according to claim 1, characterized in that: The electrode unit (22) of the flexible electrode (20) is used to be placed in a tumor cavity (R) formed after tumor resection, and the extension section (211) is used to be attached to the surface of the brain tissue (102) outside the tumor cavity (R).
3. The implantable electrode for intracranial tumor treatment according to claim 2, characterized in that: In the length direction of the flexible base layer (21), the flexible electrode (20) comprises at least two electrode units (22) arranged on the flexible base layer (21) at intervals, and the two electrode units (22) are located at non-end portions of the flexible base layer (21).
4. The implantable electrode for intracranial tumor treatment according to claim 3, characterized in that: The flexible electrode (20) is bent into a "X" shape in the implanted state, wherein at least two of the electrode units (22) are located in the tumor cavity (R) and arranged opposite to each other, and the two electrode units (22) are arranged to generate an alternating electric field; the two ends of the flexible base layer (21) itself are extension sections (211), and the two extension sections (211) of the flexible base layer (21) are used to extend out of the tumor cavity (R) in opposite directions and adhere to the surface of the brain tissue (102) outside the tumor cavity (R).
5. The implantable electrode for intracranial tumor treatment according to claim 1, characterized in that: The electrode unit (22) comprises a flexible substrate layer (221), a conductive layer (222) and a packaging layer (223) covering the flexible substrate layer (221) and the conductive layer (222) which are sequentially stacked on the flexible base layer (21).
6. The implantable electrode for intracranial tumor treatment according to claim 5, characterized in that: The material of the flexible base layer (21) includes at least one of polydimethylsiloxane, polyethylene terephthalate, polyimide or polyethylene; the material of the flexible substrate layer (221) includes at least one of thermoplastic polyurethane or medical silicone; the material of the conductive layer (222) includes at least one of carbon nanotubes, graphene, polythiophene, polyaniline, polypyrrole, gold, silver or platinum-iridium alloy; the material of the encapsulation layer (223) includes at least one of polydimethylsiloxane, polyethylene terephthalate, polyimide and a composite high dielectric constant material containing inorganic nanoparticles as fillers.
7. The implantable electrode for intracranial tumor treatment according to claim 5, characterized in that: The conductive layer (222) is in the shape of a rectangle, or The conductive layer (222) comprises a long strip-shaped trunk (2221) and a plurality of branches (2222) arranged at intervals, wherein the plurality of branches (2222) arranged at intervals are integrally connected to one side of the same trunk (2221).
8. The implantable electrode for intracranial tumor treatment according to any one of claims 1 to 7, characterized in that: The extension section (211) of the flexible electrode (20) is provided with a plurality of through holes (212) penetrating the flexible base layer (21).
9. An electric field treatment device, characterized in that: include: Control module; and The implantable electrode for treating intracranial tumors according to any one of claims 1 to 8, wherein the implantable electrode for treating intracranial tumors is electrically connected to the control module and is used to generate an alternating electric field by the implantable electrode; There are at least two implantable electrodes for treating intracranial tumors, or the implantable electrodes for treating intracranial tumors include at least two electrode units (22).
10. The electric field treatment device according to claim 9, characterized in that: The flexible electrode (20) is a first electrode, the control module is electrically connected to the flexible electrode (20), the electrode unit (22) of the flexible electrode (20) is used to be placed in a tumor cavity (R) formed after tumor resection, and the extension section (211) of the flexible electrode (20) is used to extend out of the tumor cavity (R) and adhere to the surface of the brain tissue (102) outside the tumor cavity (R); The electric field treatment device further comprises at least one second electrode (30), the second electrode (30) is also electrically connected to the control module and is used to be implanted outside the tumor cavity (R), and the control module is configured to form an alternating electric field between the flexible electrode (20) and at least one second electrode (30); Preferably, the second electrode (30) is implanted at a position below the skull (105) and above the dura mater.
11. The electric field treatment device according to claim 10, characterized in that: The electric field therapy device has an electric field therapy mode and an impedance measurement mode; Preferably, in the electric field therapy mode, the control module transmits an alternating current of a certain frequency to the flexible electrode (20) or to the flexible electrode (20) and the second electrode (30), so as to apply an electric field effect to tumor cells in a targeted area; and / or, In the impedance measurement mode, the control module transmits alternating current within a certain frequency range to the flexible electrode (20) or to the flexible electrode (20) and the second electrode (30) to measure the impedance value of the target area.
Citation Information
Patent Citations
Model apparatus used for simulating deep brain stimulation electrode implantation operation and producing method thereof
CN108305549A
Tumor treatment instrument
CN110038219A
Implantable electrode and electric field treatment equipment
CN113694371A
Implantable electrode slice and control system thereof
CN113926079A
Method and apparatus for phototherapy
CN114929333A
